celecoxib and charybdotoxin

celecoxib has been researched along with charybdotoxin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, D; Al-Jaber, M; Bakhamis, A; Bashah, M; Clapp, LH; Mohamed-Ali, V; Orie, NN; Raees, A	1

Other Studies

1 other study(ies) available for celecoxib and charybdotoxin

Article	Year
Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity. Life sciences, 2019, Dec-15, Volume: 239 Topics: Adipose Tissue; Adult; Apamin; Arteries; Celecoxib; Charybdotoxin; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Female; Gastroepiploic Artery; Humans; Indomethacin; Male; Middle Aged; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Obesity, Morbid; Omentum; Receptors, Thromboxane; Vasodilation	2019

Article

Year

Altered cyclooxygenase-1 and enhanced thromboxane receptor activities underlie attenuated endothelial dilatory capacity of omental arteries in obesity.

Life sciences, 2019, Dec-15, Volume: 239

Topics: Adipose Tissue; Adult; Apamin; Arteries; Celecoxib; Charybdotoxin; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Female; Gastroepiploic Artery; Humans; Indomethacin; Male; Middle Aged; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Obesity, Morbid; Omentum; Receptors, Thromboxane; Vasodilation

2019